Azerbaijan vs Spain: Previously treated cases tested for RR-/MDR-TB
Azerbaijan
94.0%
in 2024
Spain
94.0%
in 2024
Azerbaijan rank
72nd
Spain rank
72nd
Previously treated cases tested for RR-/MDR-TB over time
- Azerbaijan
- Spain
How they compare
Azerbaijan currently reports 94.0% against 94.0% in Spain, a difference of 0.0%.
The two have swapped places 4 times across 15 shared years of data; in 2006 it was Spain ahead.
Azerbaijan ranks 72nd and Spain ranks 72nd of 180 countries.
Across the 3 decades both report, Azerbaijan averaged higher in 2 and Spain in 1.
Head to head by decade
| Decade | Azerbaijan | Spain | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 12.0% | 13.0% | 1.0% | Spain |
| 2010s | 63.2% | 32.0% | 31.2% | Azerbaijan |
| 2020s | 98.4% | 72.0% | 26.4% | Azerbaijan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Azerbaijan or Spain?
- Azerbaijan, at 94.0% against 94.0% in Spain as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Azerbaijan and Spain?
- 0.0%, with Azerbaijan ahead.
- How many years of comparable data are there for Azerbaijan and Spain?
- 15 years are reported by both, from 2006 to 2024.
- How do Azerbaijan and Spain rank globally for previously treated cases tested for rr-/mdr-tb?
- Azerbaijan ranks 72nd and Spain ranks 72nd of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.